Application 210716

Type: ANDA
Sponsor: GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	TADALAFIL	TADALAFIL	TABLET;ORAL	2.5MG	No	No
002	TADALAFIL	TADALAFIL	TABLET;ORAL	5MG	No	No
003	TADALAFIL	TADALAFIL	TABLET;ORAL	10MG	No	No
004	TADALAFIL	TADALAFIL	TABLET;ORAL	20MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A210716-001	TADALAFIL	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29
A210716-002	TADALAFIL	TADALAFIL	5MG	TABLET / ORAL	2020-12-29
A210716-003	TADALAFIL	TADALAFIL	10MG	TABLET / ORAL	2020-12-29
A210716-004	TADALAFIL	TADALAFIL	20MG	TABLET / ORAL	2020-12-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 148 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210716-001	TADALAFIL	2.5MG	TABLET / ORAL	2020-12-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210716-002	TADALAFIL	5MG	TABLET / ORAL	2020-12-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210716-003	TADALAFIL	10MG	TABLET / ORAL	2020-12-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210716-004	TADALAFIL	20MG	TABLET / ORAL	2020-12-29	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2021-03-12 10:30 UTC	2021-03	A210716-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A210716-002	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A210716-003	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A210716-004	AB1	1	`5aa47cf7b7d7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 8 of 8 · 144 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tadalafil	TADALAFIL	Dr.Reddys Laboratories Inc	61955171-ca57-e300-1983-9472a56ca976	2020-09-30	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Dr.Reddys Laboratories Inc	22b8a2e3-d1b8-f193-45fa-77cc62a1b941	2020-01-30	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Amneal Pharmaceuticals NY LLC	2cad2167-dbd1-4df8-b407-b270487d027b	2019-10-25	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Camber Pharmaceuticals, Inc.	a3892605-4eb1-4d6e-a675-f7f7d4302f38	2019-03-26	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
68462-779	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-779	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-780	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-780	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-781	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-781	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-782	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current
68462-782	Tadalafil	Tadalafil	GLENMARK PHARMACEUTICALS INC., USA	ANDA	Current